Patient characteristics
| Characteristic . | PEL (n = 20) . | MCD (n = 19) . | HIV-DLBCL (n = 20) . |
|---|---|---|---|
| Demographic characteristics | |||
| Age, median (range), y | 44 (22-69) | 43 (28-54) | 39 (32-54) |
| Sex, male:female | 19:1 | 17:2 | 18:2 |
| Race, n (%) | |||
| White | 9 (45) | 9 (47) | 17 (61) |
| Hispanic | 4 (20) | 2 (11) | 4 (14) |
| African American | 5 (25) | 4 (21) | 6 (21) |
| African immigrant | 2 (10) | 4 (21) | 1 (4) |
| Clinical characteristics, n (%) | |||
| Kaposi sarcoma | 15 (75) | 9 (32) | 6 (30) |
| KSHV-MCD | 6 (30) | 19 (100) | 1 (4) |
| HIV viral load <100, copies/mL | 9 (45) | 14 (74) | 3 (15) |
| Laboratory parameters, median (range)* | |||
| IgG, mg/dL | 1990 (641-4900) | 3125 (1680-6050) | — |
| IgE, U/L | 68 (<1-46 950) | 397 (24-4360) | — |
| Serum FLC κ, mg/dL | 8.7 (1.5-60) | — | — |
| Serum FLC λ, mg/dL | 6.7 (1.7-45) | — | — |
| Ferritin, μg/L | 804 (87->4500) | 1455 (154-52 256) | — |
| Characteristic . | PEL (n = 20) . | MCD (n = 19) . | HIV-DLBCL (n = 20) . |
|---|---|---|---|
| Demographic characteristics | |||
| Age, median (range), y | 44 (22-69) | 43 (28-54) | 39 (32-54) |
| Sex, male:female | 19:1 | 17:2 | 18:2 |
| Race, n (%) | |||
| White | 9 (45) | 9 (47) | 17 (61) |
| Hispanic | 4 (20) | 2 (11) | 4 (14) |
| African American | 5 (25) | 4 (21) | 6 (21) |
| African immigrant | 2 (10) | 4 (21) | 1 (4) |
| Clinical characteristics, n (%) | |||
| Kaposi sarcoma | 15 (75) | 9 (32) | 6 (30) |
| KSHV-MCD | 6 (30) | 19 (100) | 1 (4) |
| HIV viral load <100, copies/mL | 9 (45) | 14 (74) | 3 (15) |
| Laboratory parameters, median (range)* | |||
| IgG, mg/dL | 1990 (641-4900) | 3125 (1680-6050) | — |
| IgE, U/L | 68 (<1-46 950) | 397 (24-4360) | — |
| Serum FLC κ, mg/dL | 8.7 (1.5-60) | — | — |
| Serum FLC λ, mg/dL | 6.7 (1.7-45) | — | — |
| Ferritin, μg/L | 804 (87->4500) | 1455 (154-52 256) | — |
—, clinical data not collected; FLC, free light chain.
Laboratory parameters for patients with PEL includes only the 19 patients included in the inflammatory milieu analysis.